Cure My Disease

Don't miss your cure!

 Log in / Sign up

A simple blood draw could detect bladder Cancer's return — a trial puts it to the test

NCT ID NCT07726602

Recruiting now Knowledge-focused Sponsor: OHSU Knight Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This study tests whether a blood test that looks for tumor DNA can detect if bladder cancer has come back after treatment. Researchers will collect blood, urine, and tissue samples from 100 people with muscle-invasive bladder cancer to see how well the test matches standard methods. The goal is to find a less invasive way to monitor for recurrence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this blood test could help catch bladder cancer recurrence earlier and reduce the need for invasive follow-up procedures.
What could go wrong
This is an early feasibility study, not a treatment trial. The test may not be accurate enough to replace standard monitoring, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infiltrating bladder urothelial carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA STAGE II BLADDER CANCER AJCC V8 STAGE IIIA BLADDER CANCER AJCC V8

Contacts and locations

Locations

  • OHSU Knight Cancer Institute

    RECRUITING

    Portland, Oregon, 97239, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.